Anastasia Xagara

10PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2026
Peripheral T-Cell Receptor β Repertoire Dynamics Correlate with Response to Anti-PD-L1 Therapy in Non-Small Cell Lung Cancer.

|Jan 28, 2026
Combinatorial Analysis of CD4+Tregs, CD8+Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Anastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos

|Jul 13, 2024
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Anastasia Xagara, Maria Goulielmaki, Sotirios P Fortis

|May 10, 2024
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.

Argyro Roumeliotou, Areti Strati, Foteini Chamchougia

|Jan 23, 2024
ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment.

Anastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis

|Aug 11, 2023
Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology.

Vasileios Vardas, Julia A Ju, Athina Christopoulou

Pageof 2

Frequent Collaborators

10 joint publications

Athanasios Kotsakis

4 joint publications

Galatea Kallergi

3 joint publications

Konstantinos Tsapakidis

3 joint publications

Vassilis Georgoulias